Displaying results 25 - 31 of 31
Public Health and Advocacy
EASL Policy Statement on Hepatitis C Elimination - RO

EASL Policy Statement on Hepatitis C Elimination - RO

PDF
View
Public Health and Advocacy
EASL Policy Statement on Hepatitis C Elimination - RU

EASL Policy Statement on Hepatitis C Elimination - RU

PDF
View
Public Health and Advocacy
EASL Policy Statement: risk-based surveillance for hepatocellular carcinoma among patients with cirrhosis

EASL Policy Statement: risk-based surveillance for hepatocellular carcinoma among patients with cirrhosis

PDF
View
Public Health and Advocacy
EASL Policy Statement: Reducing alcohol harms

EASL Policy Statement: Reducing alcohol harms

PDF
View
Metabolism, Alcohol & Toxicity
Non-alcoholic fatty liver disease: A patient guideline - GE version

Non-alcoholic fatty liver disease: A patient guideline - GE version

PDF
View
COVID-19 and the liver
Patient Association COVID-19 Toolkit final

Patient Association COVID-19 Toolkit final

PDF
View
COVID-19 and the liver
Care of Patients with Liver Disease during the COVID-19 Pandemic

Care of Patients with Liver Disease during the COVID-19 Pandemic

PDF
View